Who We Are
Innovating for a Cancer-Free Future
At KeyZell Biotech, we are a pioneering biopharmaceutical company dedicated to transforming cancer treatment. Founded in 2020, our mission is to develop innovative and effective solutions to one of the most pressing global health challenges: cancer.
With operations spanning Spain, the UK, Australia, Mexico, and Thailand, KeyZell Biotech focuses on creating personalized therapies that prioritize patient safety, efficacy, and quality of life.
Our current flagship project, the development of the drug LZ-167, represents a significant breakthrough in oncology, combining scientific excellence with a patient-centered approach.
Our Vision
To lead the next revolution in oncology by providing safer, more effective, and accessible cancer treatments for all
We aim to redefine cancer care through cutting-edge biotechnology and a relentless focus on innovation and collaboration.
Our Mission
Transforming Cancer Treatment, One Breakthrough at a Time
We are committed to:
Our Core Values
1. Innovation
2. Integrity
3. Collaboration
4. Patient-Centered Approach
Leadership Team
Meet the visionaries driving our misión:
Miguel Vilaplana
Chairman
José del Corral
Chief Executive Officer (CEO)
Tony Solanes
Chief Business Officer (CBO)
Dr.Nabil Hajji
Co-Founder & Scientist
Maria José Salado
Technical Director
Frank Rodríguez
Chief Operation Officer (COO)
Jesús Ortigueira
Strategy Manager
Alberto Pérez
Secretary of the Board
Hernan Reyes
Chief Financial Officer (CFO) & Director Australia
Kade Anderson
Thailand Director
Younes Malki
North Africa and Morocco Director
Deon Du Toit
United Kingdom Director
Our Journey So Far
Global Presence
Our international operations and collaborations enable us to address cancer treatment challenges on a global scale. We partner with leading hospitals, universities, and research centers to accelerate progress and ensure our solutions reach those who need them most.
Join Us in Transforming Cancer Treatment
Whether you are an investor, researcher, or healthcare professional, we welcome your collaboration. Together, we can create a future where cancer no longer defines lives.
